Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer
NCT00320320
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
72
Enrollment
OTHER
Sponsor class
Stopped
Poor accrual
Conditions
Colorectal Neoplasms
Metastases
Interventions
DRUG:
Irinotecan
Sponsor
Gachon University Gil Medical Center